Page last updated: 2024-08-26

mci 9038 and Endometrial Neoplasms

mci 9038 has been researched along with Endometrial Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Beckmann, L; Bokemeyer, C; Holstein, K; Langer, F; Lennartz, M; Poch, A1
Chen, G; Ding, W; Li, K; Ma, D; Nansubuga, F; Wei, J; Weng, D; Wu, P; Yang, J; Yu, R1

Trials

1 trial(s) available for mci 9038 and Endometrial Neoplasms

ArticleYear
Efficiency and safety evaluation of prophylaxes for venous thrombosis after gynecological surgery.
    Medicine, 2020, Jun-19, Volume: 99, Issue:25

    Topics: Anticoagulants; Arginine; Endometrial Neoplasms; Female; Gynecologic Surgical Procedures; Heparin, Low-Molecular-Weight; Humans; Injections, Intravenous; Middle Aged; Ovarian Neoplasms; Pipecolic Acids; Postoperative Complications; Risk Factors; Sulfonamides; Uterine Cervical Neoplasms; Venous Thrombosis

2020

Other Studies

1 other study(ies) available for mci 9038 and Endometrial Neoplasms

ArticleYear
Expression and Release of Tumor Cell Tissue Factor Triggers Recurrent Thromboembolism in a Patient with Endometrial Cancer.
    Hamostaseologie, 2023, Volume: 43, Issue:4

    Topics: Anticoagulants; Blood Coagulation Disorders; Endometrial Neoplasms; Female; Heparin, Low-Molecular-Weight; Humans; Middle Aged; Neoplasm Recurrence, Local; Thromboembolism; Thrombophlebitis; Thromboplastin; Venous Thromboembolism

2023